title: Evidence-based medicine and the selection of lipid-lowering therapy in type 2 diabetes.
authors.affiliation: Departamento de Endocrinologia y Metabolismo, Instituto Nacional de Ciencias Medicas y Nutricion, Vasco de Quiroga 15, Mexico City, Mexico. caguilarsalinas@yahoo.com
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Aguilar-Salinas
authors.forename: Roopa
authors.initials: R
authors.lastname: Mehta
authors.forename: Rita A
authors.initials: RA
authors.lastname: Gomez-Diaz
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000517:prevention & control; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male
chemical_list: D000960:Hypolipidemic Agents